Adicet Bio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ORBIMED ADVISORS LLC | 02/14/2025 | 11.45 M | $11.01 M | 0.00% | 12.60% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 8.15 M | $7.84 M | -0.86% | 8.97% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 7.54 M | $7.25 M | 0.00% | 8.30% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 3.75 M | $3.61 M | -0.19% | 4.13% |
VANGUARD GROUP INC | 02/11/2025 | 3.21 M | $3.08 M | 0.00% | 3.53% |
CARLYLE GROUP INC. | 02/13/2025 | 2.95 M | $2.84 M | 0.00% | 3.25% |
AQUILO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.53 M | $2.44 M | 0.00% | 2.79% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 2.00 M | $1.93 M | 6.55% | 2.20% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.81 M | $1.75 M | -7.37% | 2.00% |
BLACKSTONE INC. | 02/14/2025 | 1.24 M | $1.19 M | 0.00% | 1.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.03 M | $987,589 | 20.55% | 1.13% |
REGENERON PHARMACEUTICALS, INC. | 02/07/2025 | 968,183 | $931,392 | 100.00% | 1.07% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 916,500 | $881,673 | -25.58% | 1.01% |
D. E. SHAW & CO., INC. | 02/14/2025 | 847,064 | $814,876 | -7.63% | 0.93% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 811,776 | $780,929 | 7.95% | 0.89% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 794,039 | $763,866 | 12.37% | 0.87% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 767,541 | $738,597 | -0.13% | 0.84% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 703,361 | $676,633 | -0.01% | 0.77% |
STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 700,000 | $673,400 | 14.86% | 0.77% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 655,665 | $630,750 | 0.00% | 0.72% |
RBF CAPITAL, LLC | 02/14/2025 | 601,135 | $578,292 | 0.00% | 0.66% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 600,000 | $577,200 | 0.00% | 0.66% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 477,675 | $459,523 | 31.11% | 0.53% |
NORGES BANK | 02/12/2025 | 429,550 | $413,227 | 100.00% | 0.47% |
JOHNSON & JOHNSON | 02/13/2025 | 364,472 | $350,622 | 0.00% | 0.40% |
FMR LLC | 02/13/2025 | 305,907 | $294,283 | 10.77% | 0.34% |
UBS GROUP AG | 02/14/2025 | 203,229 | $195,506 | 388.48% | 0.22% |
SQUAREPOINT OPS LLC | 02/14/2025 | 184,356 | $177,350 | 100.00% | 0.20% |
JPMORGAN CHASE & CO | 02/12/2025 | 150,485 | $144,766 | 87.28% | 0.17% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 147,814 | $142,067 | 0.00% | 0.16% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 136,107 | $130,935 | 3.94% | 0.15% |
EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 111,642 | $107,400 | 0.00% | 0.12% |
DIAMETRIC CAPITAL, LP | 02/12/2025 | 85,517 | $82,267 | -22.10% | 0.09% |
03/12/2025 | 73,764 | $70,961 | 100.00% | 0.08% | |
XTX TOPCO LTD | 02/13/2025 | 68,197 | $65,606 | -76.66% | 0.08% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 51,175 | $49,230 | -71.69% | 0.06% |
VONTOBEL HOLDING LTD. | 01/30/2025 | 50,000 | $48,100 | 25.00% | 0.06% |
CASTLEVIEW PARTNERS, LLC | 01/21/2025 | 47,903 | $46,647 | -8.53% | 0.05% |
MARSHALL WACE, LLP | 02/13/2025 | 40,306 | $38,695 | -72.24% | 0.04% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 39,997 | $38,477 | -2.72% | 0.04% |
VIRTU FINANCIAL LLC | 02/11/2025 | 30,611 | $29,000 | 100.00% | 0.03% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 30,000 | $28,860 | -0.13% | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 28,909 | $27,810 | -27.69% | 0.03% |
CAXTON CORP | 02/14/2025 | 17,488 | $16,823 | 0.00% | 0.02% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 16,762 | $16,000 | -57.25% | 0.02% |
SIMPLEX TRADING, LLC | 02/11/2025 | 14,475 | $13,000 | 125.36% | 0.02% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 12,516 | $12,040 | -86.07% | 0.01% |
JANE STREET GROUP, LLC | 02/14/2025 | 12,312 | $11,845 | -83.53% | 0.01% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 11,200 | $10,774 | 409.09% | 0.01% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 10,600 | $10,176 | 100.00% | 0.01% |
Adicet Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 79 institutional investors and hedge funds held shares of Adicet Bio, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 11.45 M
TANG CAPITAL MANAGEMENT LLC: 8.15 M
RA CAPITAL MANAGEMENT, L.P.: 7.54 M
GOLDMAN SACHS GROUP INC: 3.75 M
VANGUARD GROUP INC: 3.21 M
Carlyle Group Inc.: 2.95 M
63.35% of Adicet Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 61.91 M shares in the last 24 months. This purchase volume represents approximately $67.48 M in transactions.